GFG Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.77M Buy
10,566
+2,123
+25% +$560K 0.73% 40
2026
Q2
$1.86M Buy
8,443
+859
+11% +$238K 0.51% 42
2026
Q1
$2.24M Sell
7,584
-612
-7% -$182K 0.72% 35
2025
Q4
$2.24M Sell
8,196
-262
-3% -$71.2K 0.8% 30
2025
Q3
$2.29M Buy
8,458
+1,095
+15% +$298K 0.79% 35
2025
Q2
$2.03M Buy
+7,363
New +$2M 0.61% 44
2022
Q4
– Sell
-6,197
Closed -$1.1M – 123
2022
Q3
$1.1M Buy
6,197
+309
+5% +$61.1K 0.36% 39
2022
Q2
$1.2M Buy
5,888
+807
+16% +$171K 0.37% 38
2022
Q1
$1.18M Buy
+5,081
New +$1.19M 0.35% 47

Other funds holding CME

GFG Capital's CME Position: Q3 2026 in Review

GFG Capital increased its CME Group (CME) stake by 25% in Q3 2026, buying an estimated $560K and bringing the position to 10,566 shares worth $2.77M. The position accounts for 0.73% of the portfolio, ranked #40.

GFG Capital first reported a position in CME in Q1 2022 and has held it in 9 quarters since. 368 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • GFG Capital held 10,566 shares of CME Group worth $2.77M as of Q3 2026.
  • GFG Capital bought 2,123 CME Group shares in Q3 2026, an estimated $560K.
  • CME Group made up 0.73% of GFG Capital's portfolio in Q3 2026, its #40 holding.
  • GFG Capital first reported a position in CME Group in Q1 2022 and has held it in 9 quarters since.
  • 368 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on GFG Capital's 13F filing for Q3 2026, filed 16 Oct 2026.